z-logo
open-access-imgOpen Access
24-MONTH ANALYSIS FROM PRIME, A PHASE 1B STUDY IN PATIENTS WITH PRODROMAL/MILD ALZHEIMER’S DISEASE
Author(s) -
Philip von Rosenstiel,
Sarah Gheuens,
John O’Gorman,
Ping-Chun Chiao,
C. Hock,
Roger M. Nitsch,
Samantha Budd Haeberlein,
Alfred Sandrock
Publication year - 2018
Publication title -
innovation in aging
Language(s) - English
Resource type - Journals
ISSN - 2399-5300
DOI - 10.1093/geroni/igy023.494
Subject(s) - placebo , tolerability , medicine , cohort , incidence (geometry) , clinical trial , surgery , gastroenterology , adverse effect , pathology , physics , alternative medicine , optics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom